Home|DSIJArticleDetail

Locked at the upper circuit: Entrepreneur Prathap C. Reddy earned Rs 32,36,34,267 from this small-cap multibagger stock, fueled by the upcoming Ram Mandir opening!
Locked at the upper circuit: Entrepreneur Prathap C. Reddy earned Rs 32,36,34,267 from this small-cap multibagger stock, fueled by the upcoming Ram Mandir opening!

Locked at the upper circuit: Entrepreneur Prathap C. Reddy earned Rs 32,36,34,267 from this small-cap multibagger stock, fueled by the upcoming Ram Mandir opening!

Prathap C. Reddy, an illustrious Indian entrepreneur and cardiologist who etched his name in history by establishing Apollo Hospitals

DSIJ Intelligence-3 Article rating: 3.8

A remarkable 58 per cent surge in the last three trading sessions catapulted its value by Rs 880.35, reaching a fresh 52-week high.

Healthcare company to invest Rs 3,435 crore to add 2,285 beds in next 3-4 years. Do you hold?
Healthcare company to invest Rs 3,435 crore to add 2,285 beds in next 3-4 years. Do you hold?

Healthcare company to invest Rs 3,435 crore to add 2,285 beds in next 3-4 years. Do you hold?

Expansion plan will help the hospital company to increase market share and cater to the increasing demand for quality healthcare service

DSIJ Intelligence Article rating: 4.3

Apollo Hospitals Enterprise Ltd, one of India's leading healthcare providers, is gearing up for a massive expansion drive with a capex plan of Rs 3,435 crore to add 2,285 beds over the next 3-4 years. This ambitious move is a bullish bet on the future of Indian healthcare, which is poised to grow rapidly in the coming years.

Stocks to watch: These smallcap stocks will be in focus on Thursday!
Stocks to watch: These smallcap stocks will be in focus on Thursday!

Stocks to watch: These smallcap stocks will be in focus on Thursday!

The following Small-Cap stocks are likely to be in focus on Thursday, January 12, 2022:

DSIJ Intelligence Article rating: 3.5

Among the Nifty gainers were Hindalco, Sun Pharma, BPCL, Ultra Tech Cement and HDFC Bank while Bharti Airtel, Cipla, Divis Labs, Apollo Hospital and HUL were among the top losers.  

DSIJ MINDSHARE

Mkt Commentary9-Jun, 2025

Multibaggers8-Jun, 2025

Penny Stocks8-Jun, 2025

Bonus and Spilt Shares8-Jun, 2025

Multibaggers8-Jun, 2025

Knowledge

Knowledge30-May, 2025

MF15-May, 2025

MF2-May, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered and Correspondence Office Address :
DSIJ PVT LTD. Office No - 409,
Solitaire Business Hub, Kalyani Nagar, Pune - 411006
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList